Wenjin Xi
State Key Laboratory Of Cancer Biology
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
The gut microbiota in cachexia: master regulator of neuro-immune-metabolic cross-talk.
Journal: Molecular aspects of medicine
Published: December 16, 2025
Epigenetically regulated ZCCHC9 plays a pro-tumorigenic role in glioma based on a multi-omics analysis.
Journal: International journal of biological macromolecules
Published: March 13, 2025
5-Aza combined with VPA reprograms human T lineage acute leukemia Jurkat cells into B-cell-like cells by epigenetic activation of PAX5.
Journal: Biotechnology progress
Published: November 20, 2024
Aberrant activation of a miR-101-UBE2D1 axis contributes to the advanced progression and chemotherapy sensitivity in human hepatocellular carcinoma.
Journal: Cell death discovery
Published: July 04, 2024
In vitro and in vivo validation of cytotoxicity of targeting human epidermal growth factor receptor-2 chimeric antigen receptor T (HER2-CAR-T) cells
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: May 06, 2024
A novel MYC-ZNF706-SLC7A11 regulatory circuit contributes to cancer progression and redox balance in human hepatocellular carcinoma.
Journal: Cell death and differentiation
Published: November 19, 2023
MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 18, 2021
Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.
Journal: Signal transduction and targeted therapy
Published: January 04, 2021
MiR-140-3p inhibits natural killer cytotoxicity to human ovarian cancer via targeting MAPK1.
Journal: Journal of biosciences
Published: May 10, 2020
Last Updated: 09/26/2026